Interleukin-37 attenuates acute lung injury by inhibiting inflammatory response in a mouse CLP model

Xiangjun Chen,Juan Huang,Min Chen,Yingde Huang,Nian Li,Fang Liu,Dan Pu,Taoyou Zhou
2013-01-01
Abstract:Background: Sepsis is a systemic inflammatory condition after bacterial infection, resulting in a high mortality rate and limited therapeutic outcome. Methods: The human interleukin-37 (hIL-37) protein was administrated intravenously (i.v.) after cecal ligation and puncture (CLP). After treatment 12 h, the survival time was monitored. The bacterial number, the pro-inflammatory cytokines included TNF-a alpha, IL-6, IL-1 beta and IL-17, anti-inflammatory cytokines such as IL-4 and IL-10, the chemokine CXCL2 concentrations in serum and peritoneal cavity were measured by ELISA. The myeloperoxidase (MPO) activity, malondialdehyde (MDA) and lung Wet/Dry weight ratio of lung tissues were detected. Results: hIL-37 protein rescued markedly lethality, improved survival time, reduced bacterial number, inhibited the TNF-alpha, IL-6, IL-1 beta, IL-17 and chemokine CXCL2, increased the IL-4 in blood and peritoneal cavity. But the IL-10 was unaffected. In addition, hIL-37 also decreased the MPO, MDA, lung Wet/Dry weight ratio, IL-6 and CXCL2 expression. Conclusion: Our finds suggest that hIL-37 protein is capable of improving of survival time, and acute lung injury associated with sepsis. The hIL-37 has a potential therapeutic role for septic shock.
What problem does this paper attempt to address?